KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cadre Holdings (CDRE) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Cadre Holdings (CDRE) over the last 6 years, with Q3 2025 value amounting to $849000.0.

  • Cadre Holdings' Capital Expenditures fell 1643.7% to $849000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 2902.33%. This contributed to the annual value of $5.7 million for FY2024, which is 1574.25% down from last year.
  • According to the latest figures from Q3 2025, Cadre Holdings' Capital Expenditures is $849000.0, which was down 1643.7% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Cadre Holdings' Capital Expenditures ranged from a high of $2.5 million in Q4 2023 and a low of $465000.0 during Q3 2022
  • In the last 5 years, Cadre Holdings' Capital Expenditures had a median value of $1.3 million in 2024 and averaged $1.2 million.
  • Per our database at Business Quant, Cadre Holdings' Capital Expenditures surged by 29655.91% in 2023 and then plummeted by 4808.39% in 2024.
  • Cadre Holdings' Capital Expenditures (Quarter) stood at $607000.0 in 2021, then skyrocketed by 156.34% to $1.6 million in 2022, then soared by 59.32% to $2.5 million in 2023, then tumbled by 48.08% to $1.3 million in 2024, then crashed by 34.03% to $849000.0 in 2025.
  • Its Capital Expenditures was $849000.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $1.3 million in Q1 2025.